NCT00952783已完成不适用
A 12 Month, Long-term Follow-up Study of Patients With Actinic Keratosis on Non-head Areas (Trunk and Extremities) Who Have Completed Day 57 in Study PEP005-020
Peplin11 个研究点 分布在 2 个国家目标入组 98 人开始时间: 2009年7月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 98
- 试验地点
- 11
- 主要终点
- Summarize treatment area recurrence of AK lesions in the selected treatment area
研究概览
简要总结
This study is designed to follow up patients, who have achieved complete clearance of AK lesions (lesion count of 0) at Day 57 in the PEP005-020 study, over a 12 month period to assess both recurrence of Actinic Keratosis (AK) lesions and long term safety in the selected treatment area.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
1
干预措施: Lesion count (Drug)
结局指标
主要结局
Summarize treatment area recurrence of AK lesions in the selected treatment area
时间窗: 12 months
次要结局
- Summarize long-term safety data (incidence of adverse events in the treatment area)(12 months)
研究者
研究点 (11)
Loading locations...
相似试验
已完成
不适用
A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 StudiesActinic KeratosisNCT00953732Peplin117
进行中（未招募）
不适用
Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced XerostomiaRadiation-induced XerostomiaNCT05060341MeiraGTx, LLC22
已完成
不适用
Long-term Follow-up Gene Therapy Study for RPGR- XLRPX-Linked Retinitis PigmentosaNCT04312672Janssen Research & Development, LLC42
尚未招募
Unknown
Clinical study on long-term follow-up of patients treated with PDTJPRN-UMIN000048941agasaki-university hospital40
已完成
不适用
1-Year Follow up to the 1473-IMIQ StudyKeratosisNCT00114023Graceway Pharmaceuticals, LLC84